Renal & Urology News

Revi® Implantable Tibial Neuromodulation Approved for Urgency Urinary Incontinence

The US Food and Drug Administration (FDA) has granted 510 (k) clearance for BlueWind Medical, Ltd.’s enhanced Revi® implantable tibial neuromodulator for treatment of urgency urinary incontinence (UUI ...
Morningstar

Revi® System Demonstrates Significant and Sustained Quality of Life Benefits Across All Domains for the Majority of Patients with Urgency Urinary Incontinence at 24 Months

Revi is the first iTNM device for the treatment of UUI labeled for use without prior failure of more conservative therapies, including medication. With concerns 3 about the potential link between ...
Business Wire

Two-Year Revi® Therapy Data Reinforce Sustained Efficacy and Safety of Implantable Tibial NeuroModulation in Managing Urgency Urinary Incontinence

PARK CITY, Utah--(BUSINESS WIRE)--BlueWind Medical, Ltd., a leader in implantable Tibial NeuroModulation (iTNM) and the developer of the Revi® System, today announced that new two-year data from its ...
Austin American-Statesman

How St. David's Round Rock is using ankle nerve device to stop bladder leaks in patients

"I would run. I would exercise. I would put my hands in warm water. It would cause me to dribble," said Michele Baran about her bladder leakage problem. The 63-year-old already had tried bladder sling ...
Morningstar

BlueWind Medical Receives FDA 510(k) Clearance for Enhanced Revi® Wearable Supporting Long-Term Treatment of Urgency Urinary Incontinence

Enhanced wearable builds on Revi’s strong clinical evidence, meaningful symptom relief, and exceptionally high patient satisfaction. BlueWind Medical, Ltd., a leader in implantable Tibial ...